Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 26,104 shares at $21.86 ($571K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $571k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.86 | 13,052 | $285K | 50.0% |
| 2 | $21.86 | 13,052 | $285K | 50.0% |
| Total | $21.86 avg | 26,104 | $571K | 100% |
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |